You are here

Bioiberica reinforces their presence in Russia

3 May 2015
Bioiberica

Bioiberica’s joint healthcare division and heparin business unit participated at the CPhl Russia fair, one of the most important events for the pharmaceutical sector 
The Russian pharmaceutical market is growing at a 10 percent annual rate, and is expected to reach 25 Billion Dollars by 2018

The second edition of the CPhI Rusia fair, held in Moscow on 27-29 April, brought together world leading firms specializing in the manufacture and distribution of active ingredients and finished pharmaceutical products. This year, Bioiberica’s Joint healthcare division and Heparin business unit had their own booth that presented their pharmaceutical active ingredients: chondroitin sulphate, glucosamine, hyaluronic acid, and heparin. 

The CPhl Russia fair is a unique opportunity to establish strategic contacts with the leading pharmaceutical firms in Russia. Their market is growing at a 10 percent annual rate, and, according to the fair’s organization, they expect to reach 25 billion dollars by 2018. After only two editions, the numbers of exhibitors and visitors have tripled since last year. 

Bioiberica would like to convey their appreciation to all visitors that came to our booth.

Related News

19 Apr 2022
Bioiberica

This endorses the company's commitment and responsibility to strengthen and consolidate its ethical corporate governance based on the strictest legal and regulatory standards.

11 Apr 2022
Bioiberica

Since Bioiberica was first established, our mission has been to improve the health of people, animals and plants worldwide. Our purpose – to take care of life sustainably through science – is driven by the desire to build a better future.

18 Nov 2021
Bioiberica

We only have one planet and time is running out to protect it for future generations.